These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2900730)

  • 1. Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats.
    Lin JH; Chen IW; Ulm EH; Duggan DE
    Drug Metab Dispos; 1988; 16(3):392-6. PubMed ID: 2900730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal handling of enalapril and enalaprilat: studies in the isolated red blood cell-perfused rat kidney.
    de Lannoy IA; Nespeca R; Pang KS
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1211-22. PubMed ID: 2557416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic and metabolic aspects of enalapril action.
    Lant AF; McNabb RW; Noormohamed FH
    J Hypertens Suppl; 1984 Dec; 2(2):S37-42. PubMed ID: 6100875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic studies on the competition between famotidine and cimetidine in rats. Evidence of multiple renal secretory systems for organic cations.
    Lin JH; Los LE; Ulm EH; Duggan DE
    Drug Metab Dispos; 1988; 16(1):52-6. PubMed ID: 2894955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
    J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of esterolysis of enalapril by paraoxon increases the urinary clearance in isolated perfused rat kidney.
    Sirianni GL; Pang KS
    Drug Metab Dispos; 1999 Aug; 27(8):931-6. PubMed ID: 10421621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular and not intraluminal esterolysis of enalapril in kidney. Studies with the single pass perfused nonfiltering rat kidney.
    Sirianni GL; Pang KS
    Drug Metab Dispos; 1998 Apr; 26(4):324-31. PubMed ID: 9531519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal handling of alendronate in rats. An uncharacterized renal transport system.
    Lin JH; Chen IW; Deluna FA; Hichens M
    Drug Metab Dispos; 1992; 20(4):608-13. PubMed ID: 1356743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.
    Bendtsen F; Henriksen JH
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():139-45. PubMed ID: 2550636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum enalaprilat in chronic renal failure.
    Elung-Jensen T; Heisterberg J; Kamper AL; Sonne J; Strandgaard S; Larsen NE
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):240-5. PubMed ID: 11881130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of H2 antagonists on the differential secretion of triamterene and its sulfate conjugate metabolite by the isolated perfused rat kidney.
    Muirhead MR; Somogyi AA
    Drug Metab Dispos; 1991; 19(2):312-6. PubMed ID: 1676629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay for the quantitation of lisinopril and enalaprilat.
    Worland PJ; Jarrott B
    J Pharm Sci; 1986 May; 75(5):512-6. PubMed ID: 3016233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic actions of enalapril in humans: effect of probenecid pretreatment.
    Noormohamed FH; McNabb WR; Lant AF
    J Pharmacol Exp Ther; 1990 Apr; 253(1):362-8. PubMed ID: 2158548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics and population pharmacokinetics of enalapril and lisinopril.
    Ajayi AA; Campbell BC; Kelman AW; Howie C; Meredith PA; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(6):419-27. PubMed ID: 3005181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats.
    Bak M; Shalmi M; Petersen JS; Poulsen LB; Christensen S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):33-40. PubMed ID: 8392557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights on effect of kidney insufficiency on disposition of angiotensin-converting enzyme inhibitors: case of enalapril and benazepril in dogs.
    Toutain PL; Lefebvre HP; Laroute V
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1094-103. PubMed ID: 10688628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine.
    McLean AJ; Drummer OH; Smith HJ; Froomes P; McNeil JJ
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():147-51. PubMed ID: 2550637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis.
    Kelly JG; Doyle GD; Carmody M; Glover DR; Cooper WD
    Br J Clin Pharmacol; 1988 Dec; 26(6):781-6. PubMed ID: 2853960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.